| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.084 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |